Index heavyweight RIL surged 3% to end above Rs 1,000 mark while IT majors were also the top gainers.
Companies asked to give data for three batches instead of one; move may lead to significant rise in development cost of generics
The upcoming July derivatives expiry later in the week would also add some volatility to the market proceedings.
The Sensex ended lower on unfavourable cues.
The 30-share Sensex ended higher by 177.46 points at 28,885.21 and the Nifty gained 63.90 points at 8,778.30.
Ajit Mishra, Vice President, Research, Religare Broking, answers readers's queries on stocks they own or want to buy.
Bank shares were the top gainer in early trades with Bank of Baroda up over 4%.
'To win a medal at the Olympics you need 12 to 15 Virdhawals and Sejwals.' 'We lack a swimming culture.' 'Countries like the US, Australia, France and China are powerhouses, with access to the best facilities.'
The Sensex ended at at 27,676, lower by 210 points and the Nifty broke the psychological level of 8,400 to end at 83877 down 70 points.
The S&P BSE Sensex ended 46 points lower at 24,824 and Nifty50 settled at 7,555, down by 8 points after hitting intra-day high of 7,600.45.
Data also show that several other leading domestic pharma companies have recalled their products from the US
BSE Realty index zoomed by almost 7% followed by counters like Metal, Oil & Gas, Auto, Banks, Auto, Healthcare and Power, all surging between 1-5%.
'Pay-for-delay' settlements between drug patent-holders and generics manufacturers to delay the launch of cheaper generic medicine are increasingly being scrutinised by antitrust regulators
Another year of strong performance by these export-oriented sectors likely as US economy revives and rupee is expected to be under pressure.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances